Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2078 of 6351
-
Lupus pain drug shows promise in early trial
Symptom relief CompletedThe objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE). * One hundred adults with active joint disease and at least moderate pain will be enrolled in this study to evaluate trea…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New balloon treatment shows promise for men with enlarged prostate
Symptom relief CompletedA prospective, non-randomized study. The subjects will be enrolled and treated with the Optilume BPH Prostatic DCB Dilation Catheter System at up to 8 clinical sites. The post-treatment follow-up visit can be up to 5 years. The objective of the study is to evaluate the safety an…
Phase 2 • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New drug troriluzole tested for OCD patients not helped by antidepressants
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of troriluzole as adjunctive therapy versus placebo in participants with obsessive compulsive disorder (OCD) who had an inadequate response to selective serotonin reuptake inhibitor (SSRI), clomipramine, venlafaxine, or desven…
Phase 2/3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a simple anesthesia change boost pancreatic cancer survival?
Disease control CompletedThe purpose of this randomized controlled trial is to investigate the effects of epidural anesthesia and analgesia on the overall survival,disease-free survival and recovery in patients undergoing pancreatic cancer surgery. This study will also evaluate the effects of this techni…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Blood test could sharpen lung cancer screening, study says
Diagnosis Recruiting nowThis is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy shows promise for rare gut and lung cancers
Disease control CompletedThe purpose of this study is to: * Assess overall radiographic response rate (ORR) * Assess progression-free survival (PFS) * Test the safety and tolerability of Pembrolizumab in combination with lenvatinib
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a nerve stimulator beat tough depression? new study tracks Long-Term results
Disease control Recruiting nowThe primary objective of this study is to assess short, mid and long-term clinical outcomes in patients with difficult to treat depression (such as patients with treatment resistant depression) treated with Vagus Nerve Stimulation (VNS) Therapy as adjunctive therapy.
Sponsor: LivaNova • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can your first flu shape how well the vaccine works?
Knowledge-focused Stopped earlyThe study will be designed as a prospective surveillance of the immune response to seasonal influenza vaccination in 240 healthy children and adults ages 9 and over. Study duration will be 5 years, with a participant duration of 6 months. Subjects will receive a quadrivalent inac…
Phase 4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New study aims to catch lung cancer early in those who Can't afford care
Knowledge-focused OngoingThis research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical reco…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to reduce pain and fatigue after stem cell transplant in older patients
Symptom relief OngoingAutologous stem cell transplant is beneficial to patients who are diagnosed with multiple myeloma or systemic amyloidosis. However, undesired symptoms such as weakness, fatigue, nausea, pain and sleep disturbance after transplant can contribute to complications and increase the h…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Gene therapy zolgensma tested in kids with SMA who can sit but not stand
Disease control Stopped earlyThe purpose of this trial is to evaluate the safety and tolerability of intrathecal administration of onasemnogene abeparvovec-xioi in infants and children with Spinal Muscular Atrophy with 3 copies of SMN2 and deletion of SMN1.
Phase 1 • Sponsor: Novartis Gene Therapies • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug combo aims to tame aggressive breast cancer
Disease control OngoingThis is a phase l/II study. The purpose of this study is to test the safety of the study drug neratinib in combination with a standard chemotherapy drug called capecitabine at different doses to find out what effects, if any, it has on people. Capecitabine (Xeloda®) is approved b…
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the dual RAF/MEK inhibitor, VS-6766 (RO5126766) in patients with advanced solid tumours. VS-6766 (RO5126766) is the same compound as C…
Phase 1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New vaccine combo shows promise in Tough-to-Treat breast cancer
Disease control OngoingThis research study is studying immunotherapy as a possible treatment for metastatic Triple Negative Breast Cancer (TNBC) in participants who are HLA-A2+. The drugs involved in this study are: * PVX-410 * Pembrolizumab * Hiltonol * Montanide
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for PBC patients: Long-Term safety trial of seladelpar underway
Disease control OngoingAn Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
Phase 3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New PET/MRI scan could spot elusive brain tumors in Cushing's patients
Diagnosis CompletedCushing's disease is characterized by the existence of a benign pituitary tumor developed from corticotropic cells responsible for excessive ACTH secretion. This results in hypercorticism causing high morbidity and mortality and severely impairing quality of life. The etiological…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Drug-Free relief for PMS? trial tests relaxation and taping
Symptom relief CompletedThis randomized controlled trial evaluated the effects of progressive muscle relaxation exercise, kinesio taping, and their combined application on premenstrual symptoms, perceived stress, severity of depressive symptoms, and sleep quality among university students with premenstr…
Sponsor: ASLI ER KORUCU • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Can magnetic pulses lift depression? new study investigates
Symptom relief PausedThis study will evaluate the effectiveness of intermittent Theta Burst Stimulation for patients with Major Depressive Disorder.
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Engineered immune cells target Hard-to-Treat ovarian cancer
Disease control OngoingThis phase I trial studies the side effects of genetically modified T cells and decitabine in treating patients with recurrent or refractory epithelial or non-epithelial ovarian, primary peritoneal, or fallopian tube cancer that has come back or has not responded to previous trea…
Phase 1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Keytruda takes on rare chest cancers: early trial launches
Disease control Recruiting nowThis phase I trial studies the sides effects and best dose of pembrolizumab in treating participants with thymoma or thymic cancer that cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the canc…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC